6 terminated, 5 completed, 3 recruiting, 2 active not recruiting. 18 Phase 3, 10 Phase 2.
Follow Drug Resistant Epilepsy: new trials by email Literature Review of Drug Resistant Epilepsy trials Research Report on Drug Resistant Epilepsy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cannabidiol as add-on Therapy for Children With Refractory Epilepsy (CBD-uN1que), a High-quality Individualized Approach: a Series of N-of-1 Trials Cannabidiol (CBD) oral solution, Placebo - Refractory Epilepsy in Children, Refractory Epilepsy | Phase 3 | Recruiting | UMC Utrecht | 50 | 2025-02-06 | 2026-06-25 |
| A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures BHV-7000, Placebo - Generalized Epilepsy | Phase 2 / Phase 3 | Terminated | Biohaven Therapeutics Ltd. | 27 | 2024-06-20 | 2026-03-24 |
| Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy BHV-7000, Placebo - Focal Epilepsy | Phase 2 / Phase 3 | Active not recruiting | Biohaven Therapeutics Ltd. | 390 | 2024-05-13 | 2026-08-13 |
| A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy BHV-7000, Placebo - Focal Epilepsy | Phase 2 / Phase 3 | Active not recruiting | Biohaven Therapeutics Ltd. | 390 | 2024-03-14 | 2026-09-30 |
| Placebo Controlled Study to Assess the Efficacy and Safety of Rapamycin in Drug Resistant Epilepsy Associated With Tuberous Sclerosis Complex Rapamycin, Placebo - Tuberous Sclerosis Complex | Phase 3 | Recruiting | Katarzyna Kotulska | 200 | 2023-01-23 | 2026-10-22 |
| Exogenous Ketone Esters for Drug Resistant Epilepsy Exogenous ketone ester - Drug Resistant Epilepsy | Phase 2 / Phase 3 | Recruiting | Sohag University | 60 | 2023-01-10 | 2024-11-27 |
| A Safety Study for Previously Treated Vatiquinone (PTC743) Participants With Inherited Mitochondrial Disease Vatiquinone - Inherited Mitochondrial Disease | Phase 3 | Completed | PTC Therapeutics | 101 | 2022-06-22 | 2025-12-22 |
| A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy Vatiquinone, Placebo - Mitochondrial Diseases, Drug Resistant Epilepsy | Phase 2 / Phase 3 | Terminated | PTC Therapeutics | 68 | 2020-09-28 | 2026-03-31 |
| A Study to Test the Efficacy and Safety of Padsevonil as Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy Padsevonil, Placebo - Drug-Resistant Epilepsy, Focal-Onset Seizures | Phase 3 | Terminated | UCB Biopharma SRL | 232 | 2019-03-06 | 2022-12-21 |
| Cannabis Extract in Refractory Epilepsy Study Medical Cannabis, Placebo - Drug Resistant Epilepsy | Phase 3 | Terminated | The Epilepsy Research Program of the Ontario Brain Institute | 17 | 2019-01-10 | 2020-09-11 |
| Vitamine D in Drug Resistant Epilepsy Cholecalciferol, Placebo Oral - Drug Resistant Epilepsy | Phase 3 | Completed | Centre Hospitalier St Anne | 88 | 2018-04-03 | 2024-07-12 |
| Efficacy of Ketamine Infusion Compared With Traditional Anti-epileptic Agents in Refractory Status Epilepticus Traditional Treatment (Group T), Ketamine Infusion (Group K) - Refractory Epilepsy | Phase 2 / Phase 3 | Withdrawn | University of Alabama at Birmingham | 2017-05-04 | 2021-05-21 | |
| Comparison of the Effectiveness of the Outpatient Classical Ketogenic Diet and Modified Atkins Diet on Seizures Frequency, Nutritional Status and Some Biochemical Factors in Children and Adolescents With Intractable Epilepsy Classical ketogenic diet, Modified Atkins diet - Epilepsy Intractable | Phase 2 / Phase 3 | Completed | Tehran University of Medical Sciences | 50 | 2016-09-01 | 2017-09-07 |
| Evaluation of the Modified Atkins Diet in Young Children With Refractory Epilepsy Modified Atkin Diet - Refractory Epilepsy | Phase 2 / Phase 3 | Completed | Lady Hardinge Medical College | 31 | 2012-11-01 | 2019-01-15 |
| Efficacy of a Simplified Modified Atkins Diet in Children With Refractory Epilepsy Simplified Modified Atkins Diet, Antiepileptic drugs alone - Refractory Epilepsy | Phase 2 / Phase 3 | Completed | Lady Hardinge Medical College | 81 | 2012-09-01 | 2019-01-15 |
| Low Glycemic Index Diet Therapy in Children With Refractory Epilepsy Low glycemic index diet, Control group - Refractory Epilepsy | Phase 3 | Unknown | All India Institute of Medical Sciences | 40 | 2011-06-01 | 2012-07-20 |
| Clinical Trial : TROCC (Quick Oral Treatment of Cluster Epileptic Seizures) levetiracetam - Epilepsy, Drug Resistant | Phase 3 | Terminated | University Hospital, Grenoble | 112 | 2007-02-01 | 2015-05-28 |
| STIMEP : Assessment of Subthalamic Nucleus Stimulation in Drug Resistant Epilepsy Neurostimulation - Epilepsy, Drug Resistant | Phase 2 / Phase 3 | Terminated | University Hospital, Grenoble | 4 | 2005-09-01 | 2015-05-28 |
Epilepsy (10) · Seizures (7) · Diffuse Cerebral Sclerosis of Schilder (2) · Epilepsies, Partial (2) · Leigh Disease (2) · MELAS Syndrome (2) · MERRF Syndrome (2) · Color Vision Defects (1) · Epilepsy, Absence (1) · Epilepsy, Generalized (1) · Epilepsy, Idiopathic Generalized (1) · Marijuana Abuse (1) · Mitochondrial Diseases (1) · Mitochondrial Encephalomyopathies (1)
Brain Diseases (18) · Central Nervous System Diseases (18) · Nervous System Diseases (18) · Epilepsy (8) · Pathological Conditions, Signs and Symptoms (8) · Neurologic Manifestations (7) · Signs and Symptoms (7) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Epilepsies, Myoclonic (3) · Epileptic Syndromes (3) · Genetic Diseases, Inborn (3) · Nutritional and Metabolic Diseases (3) · Autoimmune Diseases (2) · Autoimmune Diseases of the Nervous System (2) · Brain Diseases, Metabolic (2)
alpha-tocotrienol quinone (2) · Anticonvulsants (1) · Barbiturates (1) · Benzodiazepines (1) · Cannabidiol (1) · Cholecalciferol (1) · Control Groups (1) · Ketamine (1) · Levetiracetam (1) · Medical Marijuana (1) · Propofol (1) · Sensitivity Training Groups (1) · Sirolimus (1) · mycophenolic adenine dinucleotide (1) · padsevonil (1)
Biohaven Therapeutics Ltd. (3) · Lady Hardinge Medical College (2) · PTC Therapeutics (2) · University Hospital, Grenoble (2) · All India Institute of Medical Sciences (1) · Centre Hospitalier St Anne (1) · Katarzyna Kotulska (1) · Sohag University (1) · Tehran University of Medical Sciences (1) · The Epilepsy Research Program of the Ontario Brain Institute (1) · UCB Biopharma SRL (1) · UMC Utrecht (1) · University of Alabama at Birmingham (1)
France (8) · Poland (7) · United States (7) · Italy (5) · Spain (5) · United Kingdom (5) · India (4) · Australia (3) · Belgium (3) · Finland (3) · Germany (3) · Hungary (3) · Japan (3) · Netherlands (3) · Portugal (3)
Satinder Aneja, MD (2) · Vinay Penematsa, MD (2) · Abdelrahim A Sadek, MD, PhD (1) · Danielle Andrade, MD (1) · Louis Maillard, Dr (1) · Nancy Mingo, MD (1) · Peter Tai, MD (1)
PMID 30232735, PMID 32588435, PMID 36176044, PMID 38980968
2023 (4), 2018 (1)